Newsletter
Newsletter Support JNS

Israeli companies, investors meet in New York for first-ever ‘Cannabis Investment Symposium’

“Israel is a center of excellence for medical cannabis—it’s like Switzerland is for banking, the place you go to find the real experts,” says Stephen Konigsberg of Tikun Olam USA.

Israel has become the leader in cannabis research and innovation, using data to show the efficacy of cannabinoids (the active components of cannabis) in treating a range of health conditions, such as epilepsy and autism. Photo by Kobi Gideon/Flash90.
Israel has become the leader in cannabis research and innovation, using data to show the efficacy of cannabinoids (the active components of cannabis) in treating a range of health conditions, such as epilepsy and autism. Photo by Kobi Gideon/Flash90.

About 150 entrepreneurs and investors gathered in New York City last week to learn about Israel’s innovative medical cannabis industry at the first-ever “Cannabis Investment Symposium.”

“We are thrilled to introduce the best Israeli cannabis entrepreneurs and their companies to New York’s vibrant investment community and share our deep connections and insights,” said iCAN: Israel-Cannabis CEO Saul Kaye at the symposium.

“Israel is attracting investment from the world’s largest cannabis companies as well as from emerging markets in Latin America, Africa and Asia,” he said.

The international market for Israeli cannabis technology is “rapidly expanding,” said Kaye, urging the American financial community, which has previously invested in cannabis “state by state” to expand their investments to meet the global opportunity.

According to an iCan press release, cannabis is the fastest growing market in the world, with the medical cannabis industry alone expected to generate $148 billion globally by 2026 “as countries throughout the world continue to legalize its use and demand continues to grow.”

Since Israel legalized medical cannabis in the early 1990s, the Jewish state has become the leader in cannabis research and innovation, using objective measures to show the efficacy of cannabinoids (the active components of cannabis) in treating a range of health conditions such as epilepsy and autism.

At the symposium, Israeli Consul General Dani Dayan exclaimed, “If you want to understand how important and strategic this industry is, the only two living former prime ministers of Israel, Ehud Barak and Ehud Olmert, are both in the legal cannabis industry.”

Tal Ohana, mayor of Israel’s southern city of Yeruham, urged participants to visit Israel and invest, promising, “We will support you and the Israeli government will do much more including granting subsidies for land, for highly skilled labor and taxes.”

According to Stephen Konigsberg of Tikun Olam USA, “Israel is a center of excellence for medical cannabis—it’s like Switzerland is for banking, the place you go to find the real experts.”

iCAN Connect sponsors included the New York Israel Chamber of Commerce, America Israel Cannabis Association, the Israeli Economic Mission in New York, Tress capital and Vanguard Scientific Systems.

A survey found that 53.3% of respondents said that Netanyahu was best for the role, followed by Gadi Eisenkot at 26.5%.
“Evidently, the Orange County/LA Club determined that endangering the Jewish community is not disqualifying or inconsistent with ‘truth,’ ‘fairness,’ and building ‘goodwill,’” Julia Heiman of the Jewish Community Action Network said.
“I’m really concerned that we find ourselves in this place that many Americans are even questioning why we’re supporting Israel,” Rep. Dan Newhouse told JNS.
Srinivasan Muralidhar said that whether Israeli forces employed large-scale airstrikes or precise sniper fire, the aim was to kill Palestinian children in Gaza.
The city mayor said at a press conference that the Big Apple is having its “safest start to any year on record.”
“Since the fall of the Assad regime, President Ahmed Al-Sharaa and the new Syrian government have demonstrated continued commitment to counterterrorism operations within Syria,” according to Sens. Jeanne Shaheen and Elizabeth Warren and Rep. Joe Wilson.